---
title: "Piper Sandler Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293207750.md"
description: "Piper Sandler analyst David Amsellem reiterated a Buy rating on Teva Pharmaceutical (TEVA) with a $42.00 price target. Amsellem, a 5-star analyst in the Healthcare sector, maintains this stance alongside an industry-wide Strong Buy consensus for Teva, which has an average price target of $42.38."
datetime: "2026-07-20T11:27:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293207750.md)
  - [en](https://longbridge.com/en/news/293207750.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293207750.md)
generator: "portal-rs"
---

# Piper Sandler Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)

Piper Sandler analyst David Amsellem reiterated a Buy rating on Teva Pharmaceutical today and set a price target of $42.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Amsellem is a 5-star analyst with an average return of 14.8% and a 61.00% success rate. Amsellem covers the Healthcare sector, focusing on stocks such as AbbVie, Amgen, and Teva Pharmaceutical.

Currently, the analyst consensus on Teva Pharmaceutical is a Strong Buy with an average price target of $42.38.

### Related Stocks

- [TEVA.US](https://longbridge.com/en/quote/TEVA.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)

## Related News & Research

- [J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential](https://longbridge.com/en/news/297923035.md)
- [Outperforming Pharma Stock Still Has Upside Potential](https://longbridge.com/en/news/297947512.md)
- [Teva, Trump Administration Announce Intent To Reach Agreement On Affordable Medicines](https://longbridge.com/en/news/297556815.md)
- [Teva Reports Significant Prevention Of Gluten-Induced Damage in New Study](https://longbridge.com/en/news/297800772.md)
- [Teva Advances NYSE Listing With ADS Exchange Plan](https://longbridge.com/en/news/297965389.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**